Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson's disease in rats
Conclusion The present study showed a putative therapeutic role of CeO2NPs in the treatment of 6-OHDA-induced Parkinsonian rats, and suggested their antioxidant and antiapoptotic effects as possible mechanisms for elevated striatal dopamine level and improved motor performance.
Source: Neurochemistry International - Category: Neuroscience Source Type: research
More News: Antidoxidants | Brain | Nanotechnology | Neurology | Neuroscience | Parkinson's Disease | Study